241 related articles for article (PubMed ID: 18849968)
1. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
Holden LG; Prochnow C; Chang YP; Bransteitter R; Chelico L; Sen U; Stevens RC; Goodman MF; Chen XS
Nature; 2008 Nov; 456(7218):121-4. PubMed ID: 18849968
[TBL] [Abstract][Full Text] [Related]
2. The current structural and functional understanding of APOBEC deaminases.
Bransteitter R; Prochnow C; Chen XS
Cell Mol Life Sci; 2009 Oct; 66(19):3137-47. PubMed ID: 19547914
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3G subunits self-associate via the C-terminal deaminase domain.
Bennett RP; Salter JD; Liu X; Wedekind JE; Smith HC
J Biol Chem; 2008 Nov; 283(48):33329-36. PubMed ID: 18842592
[TBL] [Abstract][Full Text] [Related]
4. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.
Xie K; Sowden MP; Dance GS; Torelli AT; Smith HC; Wedekind JE
Proc Natl Acad Sci U S A; 2004 May; 101(21):8114-9. PubMed ID: 15148397
[TBL] [Abstract][Full Text] [Related]
5. Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein.
Chaurasiya KR; McCauley MJ; Wang W; Qualley DF; Wu T; Kitamura S; Geertsema H; Chan DS; Hertz A; Iwatani Y; Levin JG; Musier-Forsyth K; Rouzina I; Williams MC
Nat Chem; 2014 Jan; 6(1):28-33. PubMed ID: 24345943
[TBL] [Abstract][Full Text] [Related]
6. Insights into DNA substrate selection by APOBEC3G from structural, biochemical, and functional studies.
Ziegler SJ; Liu C; Landau M; Buzovetsky O; Desimmie BA; Zhao Q; Sasaki T; Burdick RC; Pathak VK; Anderson KS; Xiong Y
PLoS One; 2018; 13(3):e0195048. PubMed ID: 29596531
[TBL] [Abstract][Full Text] [Related]
7. Mice deficient in APOBEC2 and APOBEC3.
Mikl MC; Watt IN; Lu M; Reik W; Davies SL; Neuberger MS; Rada C
Mol Cell Biol; 2005 Aug; 25(16):7270-7. PubMed ID: 16055735
[TBL] [Abstract][Full Text] [Related]
8. RNA binding to APOBEC3G induces the disassembly of functional deaminase complexes by displacing single-stranded DNA substrates.
Polevoda B; McDougall WM; Tun BN; Cheung M; Salter JD; Friedman AE; Smith HC
Nucleic Acids Res; 2015 Oct; 43(19):9434-45. PubMed ID: 26424853
[TBL] [Abstract][Full Text] [Related]
9. Small-Angle X-ray Scattering Models of APOBEC3B Catalytic Domain in a Complex with a Single-Stranded DNA Inhibitor.
Barzak FM; Ryan TM; Kvach MV; Kurup HM; Aihara H; Harris RS; Filichev VV; Harjes E; Jameson GB
Viruses; 2021 Feb; 13(2):. PubMed ID: 33673243
[TBL] [Abstract][Full Text] [Related]
10. APOBEC2 safeguards skeletal muscle cell fate through binding chromatin and regulating transcription of non-muscle genes during myoblast differentiation.
Lorenzo JP; Molla L; Amro EM; Ibarra IL; Ruf S; Neber C; Gkougkousis C; Ridani J; Subramani PG; Boulais J; Harjanto D; Vonica A; Di Noia JM; Dieterich C; Zaugg JB; Papavasiliou FN
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2312330121. PubMed ID: 38625936
[TBL] [Abstract][Full Text] [Related]
11. Improvement of C-to-U RNA editing using an artificial MS2-APOBEC system.
Li J; Fan G; Sakari M; Tsukahara T
Biotechnol J; 2024 Jan; 19(1):e2300321. PubMed ID: 38010373
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA.
Bohn JA; Thummar K; York A; Raymond A; Brown WC; Bieniasz PD; Hatziioannou T; Smith JL
Nat Commun; 2017 Oct; 8(1):1021. PubMed ID: 29044109
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma.
Talluri S; Samur MK; Buon L; Kumar S; Potluri LB; Shi J; Prabhala RH; Shammas MA; Munshi NC
Blood Cancer J; 2021 Oct; 11(10):166. PubMed ID: 34625538
[TBL] [Abstract][Full Text] [Related]
14. Determinants of Oligonucleotide Selectivity of APOBEC3B.
Wagner JR; Demir Ö; Carpenter MA; Aihara H; Harki DA; Harris RS; Amaro RE
J Chem Inf Model; 2019 May; 59(5):2264-2273. PubMed ID: 30130104
[TBL] [Abstract][Full Text] [Related]
15. NMR-based method of small changes reveals how DNA mutator APOBEC3A interacts with its single-stranded DNA substrate.
Harjes S; Jameson GB; Filichev VV; Edwards PJB; Harjes E
Nucleic Acids Res; 2017 May; 45(9):5602-5613. PubMed ID: 28369637
[TBL] [Abstract][Full Text] [Related]
16. Computational Investigation of APOBEC3H Substrate Orientation and Selectivity.
Hix MA; Cisneros GA
J Phys Chem B; 2020 May; 124(19):3903-3908. PubMed ID: 32321250
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of
Chen SC; Ye LC; Yen TM; Zhu RX; Li CY; Chang SC; Liaw SH; Hsu CH
IUCrJ; 2021 Jul; 8(Pt 4):549-558. PubMed ID: 34258004
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces.
Shandilya SM; Nalam MN; Nalivaika EA; Gross PJ; Valesano JC; Shindo K; Li M; Munson M; Royer WE; Harjes E; Kono T; Matsuo H; Harris RS; Somasundaran M; Schiffer CA
Structure; 2010 Jan; 18(1):28-38. PubMed ID: 20152150
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.
Bohn MF; Shandilya SM; Albin JS; Kouno T; Anderson BD; McDougle RM; Carpenter MA; Rathore A; Evans L; Davis AN; Zhang J; Lu Y; Somasundaran M; Matsuo H; Harris RS; Schiffer CA
Structure; 2013 Jun; 21(6):1042-50. PubMed ID: 23685212
[TBL] [Abstract][Full Text] [Related]
20. The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.
Kitamura S; Ode H; Nakashima M; Imahashi M; Naganawa Y; Kurosawa T; Yokomaku Y; Yamane T; Watanabe N; Suzuki A; Sugiura W; Iwatani Y
Nat Struct Mol Biol; 2012 Oct; 19(10):1005-10. PubMed ID: 23001005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
